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steoclast activation is important for bone remodeling
and is altered in multiple bone disorders. This
process requires cell adhesion and extensive actin
cytoskeletal reorganization. Proline-rich tyrosine kinase 2
(PYK2), a major cell adhesion–activated tyrosine kinase in
osteoclasts, plays an important role in regulating this event.
The mechanisms by which PYK2 regulates actin cytoskeletal
organization and osteoclastic activation remain largely
unknown. In this paper, we provide evidence that PYK2
directly interacts with gelsolin, an actin binding, severing, and
capping protein essential for osteoclastic actin cytoskeletal
organization. The interaction is mediated via the focal
O
 
adhesion–targeting domain of PYK2 and an LD motif in
gelsolin’s COOH terminus. PYK2 phosphorylates gelsolin at
tyrosine residues and regulates gelsolin bioactivity, including
decreasing gelsolin binding to actin monomer and increasing
gelsolin binding to phosphatidylinositol lipids. In addition,
PYK2 increases actin polymerization at the ﬁbroblastic cell
periphery. Finally, PYK2 interacts with gelsolin in osteo-
clasts, where PYK2 activation is required for the formation
of actin rings. Together, our results suggest that PYK2 is a
regulator of gelsolin, revealing a novel PYK2–gelsolin path-
way in regulating actin cytoskeletal organization in multiple
cells, including osteoclasts.
 
Introduction
 
Osteoclastic bone resorption is a fundamental process asso-
ciated with bone remodeling. It is altered in multiple bone
disorders, including osteopetrosis and osteoporosis. Adhesion to
bone matrix initiates osteoclast activation that is characterized
by cytoskeletal reorganization, formation of sealing zones
and polarized ruffled membranes, and directional secretion
of acids and lysosomal enzymes onto the resorbing surface.
Osteoclasts cultured on glass are characterized by unique cell
adhesion structures called podosomes; dotlike aggregations
of actin that are surrounded by many focal adhesion proteins
(Marchisio et al., 1984). Podosomes are either clustered in a
ring around the cell periphery corresponding to the sealing
zone, or localized in central regions of cells (Marchisio et al.,
1984; Akisaka et al., 2001). Podosomes are similar to focal
adhesions in fibroblasts in terms of the molecular composition.
Numerous signaling molecules at focal adhesions are present
in podosomes, including integrins, cytoskeletal proteins
(paxillin, vinculin, and talin), tyrosine kinases (c-Src; Boyce
et al., 1992; Schwartzberg et al., 1997) and proline-rich tyrosine
kinase 2 (PYK2;* Duong et al., 1998; Pfaff and Jurdic,
2001), adaptor-like proteins p130
 
Cas
 
 (Cas, Crk-associated
substrate; Lakkakorpi et al., 1999) and Cbl (a negative regulator
of multiple tyrosine kinases; Tanaka et al., 1996), and phos-
phatidylinositol 3-kinase (PI 3-kinase; Chellaiah and Hruska,
1996). Unlike focal adhesions that are arrow shaped and
 
located at the ends of actin stress fibers, the core of podo-
somes is composed of actin aggregates surrounded by focal
adhesion proteins. Thus, actin-binding proteins including
gelsolin and cortactin are localized at podosomes, but not
focal adhesions (Chellaiah et al., 2000; Akisaka et al., 2001). In
addition, podosomes have a shorter life span and faster turnover
than focal adhesions, undergoing assembly and disassembly
within minutes (Tarone et al., 1985; Akisaka et al., 2001). The
assembly and disassembly of podosomes allow osteoclast migra-
tion, adhesion, and bone resorption (Kanehisa et al., 1990).
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Several lines of evidence indicate that PYK2 plays a key
role in regulating osteoclastic actin cytoskeletal organization
and bone resorption. PYK2 is highly homologous to FAK, a
major cell adhesion–activated tyrosine kinase in fibroblastic
cells (Schaller et al., 1992; Lev et al., 1995; Sasaki et al.,
1995). PYK2, but not FAK, is highly expressed in osteoclasts
(Duong et al., 1998; Pfaff and Jurdic, 2001). On adhesion,
PYK2 translocates into the Triton X-100–insoluble cyto-
skeletal fraction and localizes to podosomes and tight-sealing
zones in resorbing osteoclasts plated on bone (Duong et al.,
1998). Moreover, PYK2 becomes tightly associated with
c-Src, an important cytoplasmic tyrosine kinase implicated
in bone resorption in adherent osteoclasts (Soriano et al.,
1991). When PYK2 expression is inhibited by an adenoviral
antisense approach, osteoclasts display defects in bone re-
sorption, which are similar to that in Src
 
 
 
/
 
 
 
 osteoclasts
(Duong et al., 2001). How PYK2 functions in osteoclasts re-
mains largely unknown.
Gelsolin is an actin-binding protein important for actin
cytoskeletal organization in multiple cells including osteo-
clasts (Kwiatkowski, 1999; Chellaiah et al., 2000; Robinson
et al., 2000; Sun et al., 2000). It contains six tandem homol-
ogous repeats (S1–6) which can be separated into the N-half
(S1–3) and the C-half (S4–6; Robinson et al., 2000; Sun et
al., 2000). The S4 domain in the C-half binds to a single ac-
tin molecule when Ca
 
2
 
 
 
 is present, whereas the N-half binds
to an actin monomer (G-actin) via the S1 domain and actin
filaments (F-actin) via the S2 domain, even in the absence of
Ca
 
2
 
 
 
(Robinson et al., 2000; Sun et al., 2000). Per the tail
latch hypothesis, the C-tail in the C-half acts as a latch to in-
hibit actin binding by the N-half (Kwiatkowski et al., 1989;
Robinson et al., 2000; Sun et al., 2000). In the presence of
calcium, the C-tail releases inhibition of the N-half, which
caps and severs actin filaments. Although calcium regulates
gelsolin-actin binding positively, polyphosphoinositides neg-
atively regulate gelsolin–actin binding (Janmey and Stossel,
1987; Robinson et al., 2000; Sun et al., 2000). Functionally,
gelsolin is involved in osteoclastic podosome formation and
bone resorption (Chellaiah et al., 2000). Osteopontin, a ma-
jor bone matrix protein, stimulates gelsolin-associated Src
and PI 3-kinase activities, leading to increased actin filament
formation in avian osteoclasts (Chellaiah and Hruska,
1996). In osteoclasts derived from gelsolin
 
 
 
/
 
 
 
 mice, podo-
some assembly and osteopontin-stimulated signaling related
to motility and bone resorption are blocked (Chellaiah et al.,
2000).
In this paper, we report the interaction of PYK2 with
gelsolin in yeast two-hybrid system, in vitro, and in osteo-
clasts. We demonstrate that the focal adhesion–targeting
(FAT) domain of PYK2 interacts with the LD motif in the
C-tail of gelsolin. PYK2 phosphorylates gelsolin, decreases
gelsolin binding to actin monomer, yet increases gelsolin
binding to phosphatidylinositol. In addition, overexpression
of PYK2 in fibroblasts results in increased actin polymeriza-
tion at the cell periphery; this event depends on the presence
of gelsolin protein. Finally, we demonstrate that PYK2 acti-
vation is required for the formation of actin rings in osteo-
clasts. These results suggest that PYK2 regulates actin cy-
toskeletal organization in osteoclasts by interacting with and
regulating gelsolin.
 
Results
 
Dependence of the PYK2–gelsolin interaction on the 
FAT domain of PYK2
 
To understand the potential mechanisms by which PYK2
regulates actin cytoskeletal organization, we used the yeast
two-hybrid cloning system to identify proteins that interact
with PYK2 with the idea that they may participate in PYK2
signaling. Using PYK2 COOH terminus (amino acid 781 to
1009) as bait, we identified nearly 75 
 
 
 
-galactosidase–posi-
tive clones, of which 10 clones encoded different regions of
gelsolin. To identify the region in PYK2 that interacts with
gelsolin, we characterized several PYK2 mutants. Because the
bait contains a focal adhesion–targeting (FAT) domain and a
proline-rich sequence, we first tested whether these two do-
mains are involved in interacting with gelsolin. As shown in
Fig. 1 A, PYK2 constructs with the intact FAT domain inter-
acted with gelsolin, indicating the importance of this domain
in binding to gelsolin. Further studies demonstrated that par-
tial deletions of the FAT domain (PYK2
 
 
 
869–902 and
PYK2
 
 
 
912–956) abolished the interaction, suggesting the
dependence of this domain for gelsolin interaction (Fig. 1 A).
Previous studies have demonstrated that paxillin interacts
with the FAT domain via a secondary structure motif that re-
quires the conserved leucine residue (L990 in PYK2 and
L1024 in FAK; Tachibana et al., 1995; unpublished data).
We investigated whether the PYK2–gelsolin interaction re-
quires L990. As shown in Fig. 1 A, a point mutation in L990
(PYK2-L990S) prevented PYK2 from binding to gelsolin,
suggesting a similar interaction mechanism. Moreover, the
interaction is PYK2 specific because gelsolin did not interact
with FAK, although its FAT domain is highly homologous to
that of PYK2 (Fig. 1 A). In the control, FAK did interact
with Hic5 (Fig. 1 A), a paxillin-related protein interacting
with the FAT domain of both PYK2 and FAK (Matsuya et
al., 1998), ruling out the possibility of improper expression
of FAK construct. These results demonstrate that PYK2 spe-
cifically interacts with gelsolin via the FAT domain.
The PYK2–gelsolin interaction occurs not only in yeast
cells, but also in in vitro pull-down assays using purified pro-
teins. When gelsolin was incubated with various GST-PYK2
fusion proteins immobilized on agarose beads, GST alone did
not precipitate with gelsolin, nor did the PYK2
 
 
 
1–902 or
FAK-Cterm (Fig. 1 B). In contrast, GST-fusion proteins con-
taining the FAT domain (i.e., PYK2
 
 
 
1–781 and PYK2
 
 
 
1–
869) pulled down gelsolin. These results not only demon-
strate a direct interaction between gelsolin and PYK2, but also
further indicate the requirement for and the sufficiency of the
PYK2 FAT domain to mediate the interaction with gelsolin.
To further characterize the interaction, we assessed the rel-
ative binding affinity by ELISA-based binding assay. Gelsolin
was coated in a 96-well plate and incubated with increasing
concentrations of GST-PYK2 fusion proteins. Bound PYK2
or mutants were detected by monoclonal anti-GST antibody,
followed by anti–mouse secondary antibody conjugated to
alkaline phosphatase. As shown in Fig. 1 C, PYK2
 
 
 
1–781
bound to gelsolin in dose-dependent and saturable manners
with an EC50 value of 30 
 
 
 
 4 nM. Confirming the results
from studies above, partial deletion of the FAT domain (as in
PYK2
 
 
 
1–902) inhibited the binding (Fig. 1 C).T
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Dependence of the PYK2–gelsolin interaction on the 
COOH-terminal region of gelsolin
 
The original clones isolated from the yeast two-hybrid
screen contain the COOH-terminal region of gelsolin (Fig.
2 A; Gelsolin
 
 
 
1–258 and Gelsolin
 
 
 
1–656), suggesting
that the NH
 
2
 
 terminus and the first five gelsolin repeats
were not essential for the interaction and instead, the
COOH terminus may be critical. To identify the sequence
in gelsolin responsible for PYK2 interaction, we generated a
gelsolin mutant with a deletion of COOH-terminal 19
amino acids (Gelsolin
 
 
 
1–258/
 
 
 
C19) and examined it’s
binding to PYK2. This mutant did not interact with PYK2
(Fig. 2 A), suggesting that the COOH terminus was re-
quired for the interaction. Previous studies have shown that
the FAT domain interacts with paxillin and its family mem-
bers via the LD motif. This motif is characterized by leu-
cine-rich sequences that begin with a leucine (L) and an
aspartate (D; Brown et al., 1996; Turner, 2000). The
dependence of the PYK2–gelsolin interaction on the FAT
domain led us to investigate whether there is a similar motif
in gelsolin’s COOH terminus. Sequence analyses revealed
an LD-like motif (LDxxLxxL) in this region (residues 721
to 732) that is homologous to those in paxillin and Hic5
(Fig. 2 B). To determine whether the LD-like motif is criti-
Figure 1. Dependence of the PYK2–gelsolin interaction on the 
FAT domain in PYK2. (A) Analyses of PYK2 domains essential for 
binding to gelsolin by yeast two-hybrid assays. Yeast cells were 
cotransformed with a vector encoding the Gal4 DNA binding 
domain (Gal4-BD) fused to PYK2 or FAK constructs and Gal4 
activation domain (Gal4-AD) fused to gelsolin or Hic 5. Transformed 
yeast cells were scored for growth on Leu
 , Trp
 , and His
  plates 
and for  -gal activity; ( ) no blue after 24 h, ( ) blue after 4 h, 
(   ) blue within 30 min. (B) Direct interaction between PYK2 
and gelsolin in vitro. The purified gelsolin was incubated with 
indicated GST fusion proteins (10  g) immobilized on agarose beads. 
Bound gelsolin was resolved on SDS-PAGE and immunoblotted 
with anti-gelsolin antibodies (top). Similar amount of GST fusion 
proteins was revealed by Coomassie staining (bottom). (C) ELISA 
analysis of the interaction between PYK2 and gelsolin. Gelsolin was 
coated on 96-well plates (5 pmol/well) and incubated with increasing 
concentrations of GST-fusion proteins of indicated PYK2 or FAK 
mutants. Bound PYK2 and mutants were detected by anti-GST 
antibodies, followed by AP-conjugated secondary antibody. The 
binding activity was determined by measuring the absorbance at 
405 nm. The values were converted into relative binding with the 
value of maximal 405 nm absorbance as 100%.
Figure 2. Dependence of the PYK2–gelsolin interaction on the LD 
motif in gelsolin COOH-tail. (A) Analyses of gelsolin domains 
essential for binding to PYK2 by yeast two-hybrid assays. Yeast cells 
were cotransformed with Gal4-BD-PYK2 1–781 and Gal4-AD 
fused to different fragments or mutants of gelsolin. Transformed 
yeast cells were scored for growth in Leu
 , Trp
 , and His
  plates 
with 30 mM 3-aminotriazole and for  -gal activity; ( ) no blue after 
24 h, ( ) blue after 4 h, (   ) blue within 30 min The numbers 
represent the amino acid residues in mouse gelsolin. (B) Consensus 
sequences of LD motifs. (C) Requirement of the LD motif for PYK2–
gelsolin interaction. HEK 293 cells were transiently transfected with 
Flag-tagged gelsolin or gelsolin-L722S/D723N with Myc-tagged 
PYK2. Cell lysates were incubated with anti-Flag antibodies to 
immunoprecipitate the gelsolin complex, which was resolved on 
SDS-PAGE and immunoblotted with antibodies against Myc (top) and 
Flag (middle). Expression of PYK2 was revealed by immunoblotting 
with anti-Myc antibodies (bottom).T
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cal for interaction with PYK2, we generated point muta-
tions in this motif and assayed their binding activities (Fig.
2 A). Mutations of conserved residues including leucine
722, aspartic acid 723, or leucine 729 abolished the interac-
tion (Fig. 2 A). These results indicate that the LD-motif in
the COOH terminus of gelsolin is critical for the interac-
tion with PYK2.
To determine whether PYK2 interacts with gelsolin in
mammalian cells, we examined whether they associated in
HEK 293 cells transfected with Flag-gelsolin and Myc-
PYK2. As shown in Fig. 2 C, PYK2 was detected in immu-
noprecipitates of gelsolin, suggesting that PYK2 binds to
gelsolin in mammalian cells. As observed in yeast, the inter-
action required the LD motif of gelsolin because gelsolin-
L722S/D723N, with a mutation in the LD motif, did not
coimmunoprecipitate with PYK2 (Fig. 2 C).
 
Correlation of gelsolin tyrosine phosphorylation with 
PYK2–gelsolin interaction
 
We investigated whether PYK2 kinase activity regulates
its binding to gelsolin. Flag-tagged gelsolin was cotrans-
fected with Myc-tagged wild-type (PYK2-WT), catalytically
inactive (PYK2-KD), autophosphorylation mutant (PYK2-
Y402F) of PYK2, or FAK into HEK 293 cells. The interac-
tion of gelsolin with PYK2 was examined by coimmunopre-
cipitation. PYK2-WT associated with gelsolin as expected
(Fig. 3 A). However, PYK2-KD, PYK2-Y402F, or FAK had
significantly reduced binding with gelsolin (Fig. 3 A), indi-
cating that the catalytic activity of PYK2 may regulate the
interaction between PYK2 and gelsolin, and that gelsolin
may be a substrate of PYK2 kinase. To test this hypothesis,
we examined tyrosine phosphorylation of gelsolin by PYK2.
As shown in Fig. 3 B, gelsolin was tyrosine phosphorylated
in cells coexpressing PYK2. However, tyrosine phosphoryla-
tion of gelsolin was diminished in cells coexpressing PYK2-
KD or PYK2-Y402F, suggesting the involvement of PYK2
kinase activity in this event. The specificity of phosphoryla-
tion was demonstrated in that gelsolin was not phosphory-
lated by FAK (Fig. 3 B), probably due to its inability to in-
teract with gelsolin.
To determine whether gelsolin phosphorylation was me-
diated by PYK2, we immunopurified PYK2 and incubated
it with gelsolin in an in vitro kinase reaction containing
 
 
 
[
 
32
 
P]ATP. This reaction generated two major 
 
32
 
P-labeled
proteins at 120 and 95 kD, respectively (Fig. 3 C). The
120-kD protein was presumably PYK2 because it co-
migrated with the band that was recognized by anti-PYK2
antibody. The lower molecular weight band co-migrated
with gelsolin, suggesting that it could be phosphorylated by
PYK2. This notion was further attested by the finding that
the kinase-dead mutant was unable to phosphorylate gelso-
lin (Fig. 3 C). In a typical reaction, there was 20 pmol of
gelsolin. 1.6 pmol of hot ATP was covalently associated
with gelsolin. Assuming one tyrosine phosphorylation site,
 
 
 
8% of gelsolin is phosphorylated by PYK2 in the in vitro
kinase assay. Phosphorylation by PYK2 most occurred in
the COOH-terminal domain of gelsolin (C-gelsolin), a do-
main that interacts with PYK2 (Fig. 3, D and E). The NH
 
2
 
-
Figure 3. Regulation of PYK2–gelsolin interaction 
and gelsolin tyrosine phosphorylation by PYK2. 
(A) Regulation of PYK2–gelsolin interaction by PYK2. 
HEK 293 cells cotransfected with Myc-tagged PYK2 
or mutants with Flag-gelsolin were lysed. Immuno-
precipitations (IP) with anti-Flag antibodies were 
immunoblotted (IB) with anti-Myc (top) or anti-Flag 
(middle) antibodies. Expression of PYK2 was 
demonstrated in the bottom panel. (B) Tyrosine 
phosphorylation of gelsolin by PYK2. HEK 293 cells 
were cotransfected Flag-gelsolin with Myc-tagged 
PYK2-WT, PYK2-KD, or PYK2-Y402F and FAK. Cell 
lysates were incubated with anti-Flag antibodies 
and resulting immunocomplexes immunoblotted 
with anti-phosphotyrosine antibodies (Ptyr, RC 20). 
(C) Tyrosine phosphorylation of gelsolin by PYK2 in 
in vitro kinase assays. PYK2-WT, PYK2-KD, and 
PYK2-Y402F protein were immunoprecipitated from 
transfected HEK 293 cells and subjected to an in 
vitro kinase assay using gelsolin as a substrate. 
(D) Schematic diagrams of gelsolin mutants. The six 
repeats in gelsolin are indicated. The strength of the 
PYK2–gelsolin interaction (Gsn-PYK2) and gelsolin 
tyrosine phosphorylation (Gsn-Ptyr) in response 
to PYK2 are indicated in the right columns.    , 
strong interaction or tyrosine phosphorylation;  , no 
detectable interaction or tyrosine phosphorylation. 
(E) Tyrosine phosphorylation of gelsolin deletion 
mutants by PYK2. HEK 293 cells were transfected 
Flag-gelsolin and gelsolin mutants (N-gelsolin and 
C-gelsolin) with or without Myc-PYK2. Gelsolin or 
gelsolin mutants were immunoprecipitated with 
anti-Flag antibodies and immunoblotted with 
anti-Ptyr (RC20).T
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terminal domain of gelsolin (N-gelsolin) did not interact
with PYK2 (unpublished data), and was thus less or not
phosphorylated (Fig. 3, D and E). These results suggest the
requirement of PYK2–gelsolin interaction for gelsolin’s ty-
rosine phosphorylation and that tyrosine residues to be
phosphorylated by PYK2 are located in the COOH-termi-
nal region of gelsolin.
 
Regulation of gelsolin association with G-actin
 
Gelsolin is implicated in actin filament severing and cap-
ping in a manner dependent on gelsolin binding to actin.
Three actin binding sites are identified in gelsolin; two
in the NH
 
2
 
-terminal region (one for F-actin and one for
G-actin) and one in the COOH-terminal region that binds
G-actin in a calcium-dependent manner (Robinson et al.,
2000; Sun et al., 2000). To understand the possible role of
PYK2 in regulating gelsolin function, we examined the ef-
fect of PYK2 on gelsolin-actin monomer binding using two
methods; coimmunoprecipitation and DNaseI-Sepharose
pull-down. For coimmunoprecipitation assay, HEK 293
cells expressing gelsolin with or without PYK2 were lysed in
an extraction buffer containing 1 mM EGTA to chelate cal-
cium. Cell lysates were subjected to immunoprecipitation
for gelsolin with a washing buffer containing 30 mM
MgCl
 
2
 
 to depolymerize F-actin, and subsequent immuno-
blotting for actin. Because of the presence of EGTA in the
assay, the gelsolin-actin binding detected is believed to be
calcium-independent, and thus mediated by the NH
 
2
 
-ter-
minal region. Indeed, under these conditions, C-gelsolin
did not bind to actin, whereas N-gelsolin did (Fig. 4 A). In-
terestingly, actin interaction with the full-length gelsolin
was significantly reduced in HEK 293 cells expressing
PYK2 (Fig. 4 A), suggesting that PYK2 inhibits calcium in-
dependent gelsolin-actin monomer binding. Similar results
were obtained in experiments using the DNaseI-Sepharose
beads, which pull down actin monomers and associated
proteins (Yamamoto et al., 2001). As shown in Fig. 4 B, ac-
tin as well as full-length and N-gelsolin, but not C-gelsolin,
were detected in the pull-down complexes. Again, PYK2 re-
duced the amount of actin associated with full-length gelso-
lin (Fig. 4 B). Note that the actin association with N-gel-
solin was not inhibited by PYK2 (Fig. 4, A and B),
presumably because it did not interact directly with PYK2.
Together with the finding that COOH-terminal gelsolin
interacts with PYK2, these results suggest that PYK2 inter-
acts with the COOH-terminal region of gelsolin to regulate
the calcium-independent actin binding by the NH
 
2
 
-termi-
nal gelsolin. Attesting the specificity of the regulatory effect,
the gelsolin–actin interaction was not regulated by the ki-
nase-dead PYK2 or wild-type FAK (Fig. 4 C). Moreover,
PYK2 appeared to have little effect on gelsolin binding to
F-actin (Fig. 4 D).
Figure 4. Inhibition of gelsolin-actin binding by PYK2. HEK 293 cells expressing gelsolin, N-gelsolin, or C-gelsolin with or without PYK2 
were lysed, and cell lysates were subjected to analyses of gelsolin-actin monomer binding by coimmunoprecipitation of gelsolin with actin 
(A) and DNaseI-Sepharose pull-down (B). (C) Coimmunoprecipitation of gelsolin with actin in HEK 293 cell lysates expressing gelsolin with 
PYK2, PYK2-KD, or FAK. (D) Gelsolin-F-actin cosedimentation. HEK 293 cells expressing the indicated proteins were lysed in a buffer 
containing 1 mM EGTA to chelating calcium. In coimmunoprecipitation assays, 30 mM MgCl2 was added in the washing buffer to 
depolymerize actin filaments.T
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Regulation of gelsolin association with 
PI(4,5)P2 association
 
Previous studies have shown that gelsolin interacts with
PI(4,5)P2, and that this interaction negatively regulates gelso-
lin-actin association (Janmey and Stossel, 1987; Robinson et
al., 2000; Sun et al., 2000). PYK2 may modulate PI(4,5)P2-
gelsolin binding to inhibit gelsolin-actin binding. To test this
hypothesis, we examined the effects of PYK2 on gelsolin–
PI(4,5)P2 interaction. PI(4,5)P2 beads were incubated with
HEK 293 cell lysates expressing Flag-gelsolin with or without
PYK2. Gelsolin bound to the beads was detected by immuno-
blotting with anti-Flag antibodies. PI(4,5)P2-associated gelso-
lin was significantly increased when PYK2 was coexpressed
with gelsolin (Fig. 5 A). This effect appeared to be PYK2 spe-
cific and require the kinase activity of PYK2 because FAK and
the catalytically inactive PYK2-KD failed to increase in gelso-
lin-PI(4,5)P2 binding (Fig. 5 A). Furthermore, PI(4,5)P2-
associated gelsolin appeared to be tyrosine phosphorylated (Fig.
5 A). Although PI(4,5)P2 beads failed to precipitate PYK2,
the beads did precipitate PYK2 when gelsolin was coexpressed
(Fig. 5 A), indicating the formation of a ternary complex
of PI(4,5)P2–gelsolin–PYK2. Next, we examined whether
PYK2 regulation of PI(4,5)P2-gelsolin binding depends on
PYK2–gelsolin interaction. N-gelsolin contains PI(4,5)P2,
but not PYK2 binding site, whereas C-gelsolin has PYK2, but
not PI(4,5)P2 binding site (Janmey and Stossel, 1987; Robin-
son et al., 2000; Sun et al., 2000). PYK2 increased PI(4,5)P2
binding to full-length gelsolin, but not N- or C-gelsolin (Fig.
5 B), suggesting the requirement of the COOH-terminal re-
gion of gelsolin. These results suggest that PYK2 regulation of
gelsolin binding to PI(4,5)P2 may play a role in inhibiting
gelsolin–G-actin interaction.
 
PYK2 stimulation of actin polymerization at 
fibroblastic cell periphery
 
Gelsolin caps actin filaments at the barbed ends. This event
requires gelsolin–G-actin binding and is negatively regulated
by gelsolin–PI(4,5)P2 association (Janmey and Stossel, 1987;
Figure 5. PYK2 stimulation of gelsolin-PI(4,5)P2 association. 
(A) PI(4,5)P2 binding to gelsolin or PYK2–gelsolin complexes in 
HEK 293 cells coexpressing Flag-gelsolin with or without PYK2-WT, 
PYK2-KD, or FAK. (B) Co-expressing PYK2 with Flag-gelsolin or 
gelsolin deletion mutants. HEK 293 cell lysates expressing indicated 
proteins were incubated with PI(4,5)P2 beads. PI(4,5)P2-bound 
proteins, such as gelsolin, PYK2, or FAK were detected by immuno-
blotting with indicated antibodies.
Figure 6. Increase in actin polymerization at fibroblastic cell 
periphery by PYK2. 10T1/2 or embryonic fibroblasts derived from 
gelsolin knock-out (gsn / ) or wild type (gsn / ) mice were 
transiently transfected with indicated constructs. Transfected cells 
were trypsinized, replated onto fibronectin-coated coverslips for 
2–4 h, fixed, and stained with indicated antibodies. Phalloidin was 
used to stain polymerized actin filaments. Open arrows indicate cells 
without PYK2 expression; Closed arrows indicate PYK2 expressing 
cells. Bar, 50  m.T
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Robinson et al., 2000; Sun et al., 2000). The reciprocal rela-
tionship between an increase in gelsolin-PI(4,5)P2 binding
and an inhibition of gelsolin–G-actin association by PYK2
suggests that PYK2 may lead to gelsolin uncapping and actin
filament polymerization. To test this hypothesis, we exam-
ined actin polymerization in 10T1/2 fibroblasts expressing
PYK2-WT by phalloidin staining. As shown in Fig. 6, fibro-
blasts expressing PYK2-WT, but not FAK-WT, exhibited in-
creased phalloidin staining at the cell periphery. Interestingly,
although expressed PYK2 was distributed in both cell periph-
ery and cytoplasm (Fig. 6 D), activated PYK2 stained by
phosphotyrosine 402 (PY402) antibody was mainly located
at the cell periphery (Fig. 6 G). This staining pattern was in
close proximity with that of phalloidin in PYK2 expressing
cells, suggesting that activated PYK2 may contribute to the
increased actin polymerization at the cell periphery. More-
over, in fibroblasts derived from gsn
 
 
 
/
 
 
 
 or gsn
 
 
 
/
 
 
 
 mice,
endogenous PYK2 was localized at focal adhesions (Fig. 6,
P–U), a finding consistent with previous report in smooth
muscle cells or 10T1/2 fibroblasts (Brinson et al., 1998; Du
et al., 2001). On PYK2 expression, Gsn
 
 
 
/
 
 
 
 fibroblasts ei-
ther remained unchanged in shape or had neurite-like pro-
cesses (Fig. 6, M–R). However, PYK2 expression in gsn
 
 
 
/
 
 
 
cells led to apoptosis (unpublished data), a finding consistent
with previous report (Xiong and Parsons, 1997). These re-
sults suggest that PYK2 induction of actin filaments at the
cell periphery and apoptosis requires gelsolin.
 
Interaction of PYK2 with gelsolin and their 
colocalization in osteoclasts
 
As an initial step to understand possible roles of PYK2–
gelsolin interaction in vivo, we examined expression and in-
teraction of PYK2 and gelsolin in different cells including
10T1/2 fibroblasts and mouse osteoclasts. Western blot
analysis demonstrated that both PYK2 and gelsolin were
highly expressed in mouse osteoclasts, but less in 10T1/2 fi-
broblasts (Fig. 7 A). Thus, we determined whether endoge-
nous PYK2 and gelsolin interact in mouse osteoclasts. As
shown in Fig. 7 B, PYK2 was detected in gelsolin, but not in
nonspecific IgG, immunocomplexes, indicating that gelsolin
associated with PYK2 specifically in mouse osteoclasts. This
interaction appeared to be strong with 5–10% of gelsolin as-
sociated with PYK2 immunocomplexes (Fig. 7 B). More-
over, this interaction was not only observed in mouse osteo-
clasts, but also in chicken osteoclasts (Fig. 7 B).
Next, we assessed whether gelsolin is tyrosine phosphory-
lated in mouse osteoclasts when PYK2 is activated. Mouse os-
teoclastic precursors cultured in suspension dishes were held
in suspension for 2 h, remained in suspension dishes, or cul-
tured in tissue culture dishes with M-CSF and Rank ligand
for different times. PYK2 was activated in these cultured con-
ditions except when cells were held in suspension (unpub-
lished data). Gelsolin was immunoprecipitated from these
cell lysates and its tyrosine phosphorylation was detected by
immunoblotting with antibodies against phosphotyrosine
(RC20). As shown in Fig. 7 C, three tyrosine phosphorylated
proteins were detected in gelsolin immunoprecipitates. Two
proteins appeared to co-migrate with PYK2 and Src, a kinase
that phosphorylates gelsolin in vitro (De Corte et al., 1997,
1999), and one protein band co-migrated with gelsolin (Fig. 7
C). This result suggests that gelsolin in osteoclasts may be ty-
rosine phosphorylated when PYK2 and Src are activated.
Then, we examined subcellular localizations of PYK2 and
gelsolin in mouse osteoclasts. Mouse osteoclasts, indicated
by the tartrate-resistant acid phosphatate (TRAP) staining
(Fig. 7 D), were plated on glass coverslips, fixed, and im-
Figure 7. Interaction and colocalization of gelsolin with PYK2 in 
osteoclasts. (A) Western blot analysis of the expression of PYK2, FAK, 
and gelsolin in 10T1/2 fibroblasts and mouse osteoclasts. Cell lysates 
(10  g of protein) were subjected to SDS-PAGE and immunoblotting 
using indicated antibodies. (B) Coimmunoprecipitation of gelsolin 
with PYK2 in both mouse and chicken osteoclasts. Cell lysates (500  g) 
were incubated with anti-PYK2 (PYK2 IgG), anti-gelsolin (Gelsolin 
IgG), or nonspecific mouse IgGs (Mouse IgG), and resulting immuno-
complexes immunoblotted with antibodies against gelsolin or 
PYK2. Lysate inputs (50  g, cell lysates) were loaded. (C) Tyrosine 
phosphorylation of gelsolin in mouse osteoclasts. Mouse osteoclastic 
precursors cultured in suspension dishes were held in suspension 
for 2 h (Suspension), remained in suspension dishes (Attach on plastic), 
or cultured in tissue culture dishes with M-CSF and Rank ligand for 
1 d (Attach, day 1) and 5 d (Attach, day 5). Immunoprecipitations 
with anti-gelsolin antibodies were immunoblotted with antibodies 
against phosphotyrosine (RC20) or gelsolin. Open arrows indicate 
the proteins that co-migrate with PYK2 or Src, and the closed arrows 
indicate the protein that co-migrates with gelsolin. (D) TRAP staining of 
mouse osteoclasts. Mouse osteoclasts were stained with TRAP, marker 
of osteoclasts. Both fused (c) and prefused osteoclasts (a and b) were 
positive for TRAP staining. (E) Coimmunostaining of PYK2 with 
gelsolin in mouse osteoclasts. (F) Coimmunostaining of the active 
PYK2 (PY402) with F-actin in chicken osteoclasts. Mouse or chicken 
osteoclasts were fixed with 4% PFA, permeabilized with 1% Triton
X-100, and stained with indicated antibodies. Bars (D–F), 50  m.T
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munostained using antibodies against PYK2 (polyclonal;
United Biomedical, Inc.) and gelsolin (monoclonal). The
PYK2 antibody was specific and did not cross-react with
overexpressed FAK (Du et al., 2001). PYK2 was distributed
in dot- or ringlike podosomes at the cell periphery. Gelsolin
was colocalized with PYK2 in dotlike podosomes (Fig. 7 E,
solid arrow). However, the two proteins only partially over-
lap in ring-like podosomes (Fig. 7 E, open arrow). The
staining did not appear to be nonspecific because immu-
nostaining osteoclasts with secondary antibodies alone gen-
erated the background staining that was different from stain-
ing by PYK2 or PY402 antibodies (unpublished data). These
results imply that PYK2 and gelsolin may function as a com-
plex to regulate podosome and actin ring formation in
mouse osteoclasts. In addition to mouse osteoclasts, chicken
osteoclasts were used to examine PYK2 subcellular localiza-
tion. The active PYK2 stained with the PY402 antibody was
codistributed with F-actin labeled by phalloidin at podo-
somes in the cell periphery (Fig. 7 F), conforming the results
from mouse osteoclasts.
 
Role of PYK2 activity in the formation of actin rings 
and cell periphery podosomes in osteoclasts
 
The interaction of PYK2 with gelsolin in osteoclasts suggests
a role of PYK2 in regulating osteoclastic actin cytoskeletal or-
ganization. To address this hypothesis, adenoviruses encoding
PYK2-KD, a dominant-negative mutant of PYK2, and GFP
were generated and used to infect cultured mouse osteoclasts.
Infected cells were fixed and immunostained with phalloidin
to examine the actin ring and podosome structures, two im-
portant actin-associated structures in mouse osteoclasts. Fig. 8
A shows the expression and tyrosine phosphorylation of
PYK2 and its mutant in virus-infected mouse osteoclasts. Al-
though nearly all osteoclasts (
 
 
 
90%) infected with the ade-
novirus encoding GFP exhibited normal actin ring and
podosome structures, the majority (
 
 
 
80%) of osteoclasts ex-
pressing PYK2-KD had no visible actin ring structures (Fig.
8, B and C), indicating that PYK2 activity is required for the
actin ring formation in osteoclasts. Most dotlike podosomes
were distributed at the cell periphery in osteoclasts expressing
GFP adenovirus (Fig. 8 D). In contrast, podosomes were con-
centrated at central regions of the cytoplasm in PYK2-KD ex-
pressing osteoclasts (Fig. 8 D). These results are consistent
with the previous report that osteoclasts expressing PYK2
anti-sense RNA exhibit major defects of actin ring formation
(Duong et al., 2001). These results suggest that PYK2 activa-
tion may be required for the formation of cell periphery po-
dosomes, or alternatively, translocation of podosomes from
central regions to the cell periphery, which is important for
the assembly of actin ring structures.
 
Discussion
 
This paper presents evidence for a role of the PYK2–gelsolin
interaction in regulating actin cytoskeletal organization,
which lead us to propose a model detailed in Fig. 9. In this
model, PYK2, in response to extracellular stimuli, interacts
with gelsolin. The affinity of gelsolin for PI(4,5)P2 is in-
creased, but gelsolin binding to actin monomer is decreased.
We speculate that this event may lead to the uncapping of
actin filaments at the barbed ends, increase in actin polymer-
ization at the cell periphery, and regulation of osteoclastic
actin ring formation (Fig. 9).
The identification of the PYK2–gelsolin interaction sug-
gests that PYK2 is an important regulator of gelsolin in actin
polymerization. Gelsolin binds to two actin monomers in
the presence of calcium. One actin monomer remains bound
after chelation of calcium with EGTA (Wang and Bryan,
1981; Lind et al., 1982; Kurth et al., 1983). The EGTA sta-
ble gelsolin–actin complex appears to have a higher affinity
for barbed filament end than free gelsolin (Janmey et al.,
1985). Our results demonstrate that PYK2 inhibits this
EGTA stable gelsolin-actin monomer association. This inhi-
bition may lead to the generation of free actin barbed ends
and increase of actin polymerization at cell periphery. This
notion is supported by the findings that active PYK2 is local-
ized at the cell periphery in fibroblasts and osteoclasts and
that cells expressing PYK2 exhibit increased gelsolin-depen-
Figure 8. Requirement of PYK2 activity for the formation of actin 
rings and cell peripheral podosomes in mouse osteoclasts. 
(A) Western blot analysis of PYK2 expression in osteoclasts infected 
with adenoviruses expressing GFP, PYK2-WT, or PYK2-KD by 
anti-PYK2 and PY402 antibodies. (B) Quantitative analysis of mouse 
osteoclasts with intact actin rings after infection. (C) Immunostaining 
of mouse osteoclasts infected with indicated adenoviruses. 
(D) Amplified images from C. Bars (C and D), 50  m.T
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dent actin polymerization at the cell periphery. In addition,
PYK2 may increase gelsolin-severing activity by decreasing
the EGTA stable gelsolin–actin complex and increasing free
gelsolin that can sever actin filaments in the presence of cal-
cium (Janmey et al., 1985). Although these results suggest
that gelsolin may be a target of PYK2 in regulating actin
polymerization, they do not exclude gelsolin-independent
mechanisms. In addition to gelsolin, we believe PYK2 may
regulate functions of other proteins important for actin poly-
merization. These proteins include Rho family GTPases
(Ren et al., 2001) and WASP family proteins.
The exact mechanisms by which PYK2 decreases gelsolin–
actin interaction remain to be identified. The dependence of
the PYK2 regulation of gelsolin–actin interaction on the ki-
nase activity suggests an important role of tyrosine phos-
phorylation. An intriguing hypothesis is that on phosphor-
ylation by PYK2, gelsolin has a lower affinity for actin
molecules due to a conformational change. Note that gelso-
lin tyrosine phosphorylation was very low when PYK2 was
activated in osteoclasts. This may suggest that other mecha-
nisms, in addition to tyrosine phosphorylation of gelsolin,
are involved in PYK2 regulation of gelsolin activity. Earlier
studies have shown that the gelsolin–actin interaction is reg-
ulated by PI(4,5)P2 (Janmey and Stossel, 1987; Robinson et
al., 2000; Sun et al., 2000). There is a reciprocal relationship
 
between gelsolin binding to actin and that to PI(4,5)P2. It is
believed that binding to PI(4,5)P2 causes a conformational
change in gelsolin that causes the release of actin (Janmey
and Stossel, 1987; Robinson et al., 2000; Sun et al., 2000).
Interestingly, our studies show that PYK2 increases
PI(4,5)P2 binding to gelsolin. It seems reasonable that
PYK2 inhibits the gelsolin-actin binding by increasing the
association with PI(4,5)P2. It is worth pointing out that the
kinase-inactive mutant PYK2 also increased, albeit weakly,
the gelsolin–PI(4,5)P2 interaction, which may suggest that
the binding to PYK2 may regulate gelsolin’s conformation.
Moreover, PYK2 stimulates PI4-kinase (unpublished data),
and Nirs, 
 
Drosophila
 
 rdgB homologues in human and mouse
with phosphoinositol transfer activity (Lev et al., 1999).
Both PI4-kinase and Nirs are important for generation of
PI(4,5)P2 in the cell. Thus, an increase in PI(4,5)P2 supply
in the PYK2 signaling complex may be an mechanism to in-
crease the gelsolin-PI(4,5)P2 binding in vivo.
Actin rings at cell periphery of osteoclasts contain highly
dynamic clustered F-actin filaments. Stimulation of integrin
leads to activation of gelsolin-associated PI 3 kinase and de-
crease in gelsolin-actin association, both of which are impor-
tant for actin cytoskeleton reorganization (Chellaiah and
Hruska, 1996). Our studies may provide a link between in-
tegrin stimulation and downstream actin polymerization.
Interestingly, PYK2 and gelsolin colocalize at the podosomes
and actin rings at the cell periphery of osteoclasts. Osteo-
clasts expressing PYK2-KD exhibit defects in the formation
of actin rings at the cell periphery, but not dotlike podo-
somes in the cytoplasm. These observations support a role of
PYK2 as an important regulator of gelsolin in actin cytoskel-
etal organization induced by various stimuli that activate
PYK2 in addition to integrin engagement (Fig. 9). It is wor-
thy pointing out that some data in this paper were from in
vitro and overexpression experiments, and thus need to be
confirmed in in vivo models.
 
Materials and methods
Reagents
mAbs were purchased from Santa Cruz Biotechnology, Inc. (anti-Myc),
Sigma-Aldrich (anti-Flag), and Transduction Laboratories (anti-PYK2 and
anti-gelsolin). pAbs against PYK2 and PY402 in PYK2 were obtained from
Upstate Biotechnology and Biosource International, respectively. The
cDNA encoding mouse gelsolin was purchased from the American Type
Culture Collection. Gelsolin knockout (Gsn / ) mice were provided by
Dr. David Kwiatkowski (Brigham and Women’s Hospital, Boston, MA;
Witke et al., 1995). The Gsn /  mouse was maintained in mixed Sv129-
BALB/c and Sv129-C57/bl backgrounds. Littermates that were Gsn /  de-
rived from Gsn /  matings were used for generation of dermal fibroblasts.
Yeast two-hybrid studies
The PYK2 COOH terminus (amino acid residues 781–1009) subcloned
into pGBT10 (pGBT10-PYK2 1–781) was used as bait to screen mouse
brain cDNA libraries fused to the GAL4 transcriptional activation domain
(Gal4-AD; Ren et al., 2001). The Y190 yeast strain was first transformed
with pGBT10-PYK2 1–781, and subsequently with the mouse brain
cDNA library. Positive clones were screened out on plates lacking leucine,
tryptophan, and histidine with 30 mM 3-aminotriazole and by filter assays
for  -galactosidase activity. Plasmid DNA was purified from the His
 
 -gal
  colonies, and was retransformed into yeast with different bait vec-
tors to determine specificity. To characterize binding between PYK2 and
gelsolin, plasmids encoding PYK2, gelsolin, or their mutants were cotrans-
formed into yeast Y190; interactions were characterized by growth and by
 -galactosidase activity (Ren et al., 2001).
Figure 9. A working hypothesis by which PYK2 regulates actin 
cytoskeletal organization in osteoclasts. Osteoclastic adhesion to bone 
matrix activates PYK2 and increases PYK2–gelsolin interaction. 
Gelsolin binding to phosphatidylinositol is increased. At the same time, 
the gelsolin–actin monomer interaction is decreased, which prevents 
gelsolin from capping actin filaments at barbed ends. Subsequently, 
the growth of actin filaments at cell periphery is increased, which is 
important for actin ring formation in osteoclasts.T
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Expression vectors
The cDNAs of FAK and PYK2 were subcloned into mammalian expression
vectors downstream of a Myc epitope tag (MEQKLISEEDL) as described
previously (Xiong and Parsons, 1997). The cDNAs encoding gelsolin or its
mutants were amplified by PCR, and were subcloned into mammalian ex-
pression vectors downstream of a Flag epitope tag (MDYKDDDDKGP) un-
der the control of the CMV promoter (Ren et al., 2001). PYK2-KD (kinase
inactive mutant [lysine 457 to alanine]) and PYK2-Y402F (autophosphory-
lation mutant [tyrosine 402 to phenylalanine]) were generated as de-
scribed previously (Xiong and Parsons, 1997). Other point mutations in
PYK2 or gelsolin were also generated by PCR amplification (QuikChange
®;
Strategene). Mutations were verified by DNA sequencing.
Cell culture and transfection
HEK 293 cells and 10T1/2 fibroblasts were maintained in DME supple-
mented with 10% FCS, 100  g/ml penicillin G, and 100  g/ml streptomy-
cin (GIBCO BRL). The calcium phosphate precipitation method was used
to transfect HEK 293 cells, and 20–30  l SuperFect
® (Invitrogen) was incu-
bated with the constructs to transfect 10T1/2 cells.
Dermal fibroblasts derived from Gsn /  and Gsn /  mice were gen-
erated as described previously (Witke et al., 1995; Azuma et al., 1998). In
brief, skin tissue extracts from the mice were prepared by homogenization.
Dermal fibroblasts were maintained in DME supplemented with 10% FCS.
SuperFect
® was used for transfection.
Mouse osteoclasts were generated by in vitro differentiation of mouse
bone marrow macrophages (BMMs) by RANKL/M-CSF (Feng et al., 2001).
In brief, whole bone marrow cells were flushed out of mouse long bones
and plated on 150-mm tissue culture plates in  -MEM containing 10% FBS
plus 10 ng/ml recombinant M-CSF (R&D Systems). Cells were incubated at
37 C with 5% CO2 overnight. Nonadherent cells were harvested 12 h later
and subjected to Ficoll-Hypaque gradient to purify BMMs. Isolated BMMs
were then cultured in  -MEM containing 10% FBS plus 10 ng/ml recombi-
nant M-CSF. To generate osteoclasts, 10
5 BMMs were plated in one well of
a 24-well plate in  -MEM containing 10% FBS in the presence of 10 ng/ml
recombinant M-CSF and 88 ng/ml recombinant GST-RANKL. Osteoclasts
began to form 96 h later. The identity of osteoclasts was confirmed by
TRAP staining using the Leukocyte Acid Phosphatase Kit (Sigma-Aldrich).
Chicken osteoclasts were generated as described previously (Williams et
al., 1996).
Protein pull-down assays
GST-fusion protein pull-down assay was performed as described previ-
ously (Ren et al., 2001). DNaseI-Sepharose pull-down assay was per-
formed as described previously (Yamamoto et al., 2001). In brief, tran-
siently transfected HEK 293 cells were lysed in the extraction buffer
containing 0.75% Triton X-100, 60 mM Pipes, 25 mM Hepes, pH 7.2, 1
mM EGTA, 2 mM MgCl2, 1 mM sodium vanadate, 10  g/ml leupeptin,
40  g/ml aprotinin, 80  g/ml benzamidine, and 1 mM PMSF. Cell ly-
sates were incubated with DNaseI immobilized on Sepharose beads at
4 C for 1 h. Actin monomers bind DNaseI and many proteins, such as
gelsolin, that bind actin monomers are pulled down as well. The bound
protein complexes were analyzed by SDS-PAGE followed by immuno-
blotting.
ELISA
ELISA based binding assay was performed as described previously (Luo et
al., 2002). In brief, 96-well MaxiSorp™ immunoplates (Nunc) were coated
with purified human gelsolin (5 pmol/well; Cytoskeleton, Inc.) in BBS (125
mM borate, 75 mM NaCl at pH 8.5) overnight at 4 C. Plates that were
washed three times in PBS and preblocked were incubated with different
fragments of GST-PYK2 or FAK fusion proteins overnight at 4 C, and were
washed four times in BBS, followed by incubating with mouse anti-GST
mAb (1:20,000) for 2 h at RT. After washing four times in BBS and once
with substrate buffer (0.1 mM MgCl2, 5% vol/vol diethanolamine, pH 9.8),
plates were subjected to color reaction by incubating with 1 mg/ml PNPP
(para-nitrophenyl phosphate) in substrate buffer. Absorbance at 405 nm
was read with a microplate reader. All values were converted to relative
binding by defining maximal absorbance as 100%.
Immunoprecipitation
PYK2–gelsolin coimmunoprecipitation was performed as described previ-
ously (Ren et al., 2001). Assay of gelsolin-actin association was performed
as described previously (Chaponnier et al., 1987; Lind et al., 1987) with
modification. Gelsolin constructs were cotransfected with empty vector or
PYK2 constructs in HEK 293 cells. 48 h after transfection, cells were lysed in
extraction buffer containing 0.75% Triton X-100, 60 mM Pipes, 25 mM
Hepes, pH 7.2, 1 mM EGTA, 2 mM MgCl2, 1 mM sodium vanadate, 10  g/
ml leupeptin, 40  g/ml aprotinin, 80  g/ml benzamidine, and 1 mM PMSF.
Flag-tagged gelsolin was immunoprecipitated with anti-Flag M2 affinity aga-
rose beads (Sigma-Aldrich), washed three times with the extraction buffer,
and once with 0.3 M MgCl2 included in the extraction buffer. The immuno-
precipitates were analyzed by SDS-PAGE followed by immunoblotting.
Actin co-sedimentation assay
Transfected HEK 293 cells were rinsed twice with ice cold PBS and
then collected in 0.5 ml of the binding buffer (10 mM imidaxole, pH
7.2, 75 mM KCl, 5.0 mM MgCl2, and 0.5 mM DTT) supplemented with
1 mM EGTA, 1  g/ml leupeptin, 1  g/ml aprotinin, and 1  g/ml pepsta-
tin A. Cells were homogenized, followed by centrifugation at 100,000 g
for 1 h at 4 C in a TLA-120.1 rotor (Beckman Coulter). Muscle mono-
mer actin (Cytoskeleton, Inc.) was diluted to 2.5 mg/ml in binding
buffer and incubated for 1 h at RT. Polymerized actin was stabilized by
adding phalloidin (Molecular Probes, Inc.) to a final concentration of
25  g/ml. 5.5  M F-actin was added to clarified cell lysates (50  g to-
tal protein) to final volume of 200  l, and the mixtures were incubated
at RT for 30 min. Samples were centrifuged at 100,000 g for 30 min at
20 C. Pellet and supernatant were analyzed by SDS-PAGE and Western
blotting.
In vitro phosphorylation of gelsolin
2  g purified gelsolin was incubated with immunoprecipitated PYK2 or
mutants in 40  l phosphorylation buffer containing 10 mM Hepes, pH 7.6,
10 mM magnesium acetate, 5  Ci of  [
32P]ATP, and 50  M ATP for 30
min at 30 C. Phosphorylated gelsolin and PYK2 were subjected to SDS-
PAGE analysis. The dried gel was exposed to x-ray film. The corresponding
PYK2 or gelsolin protein bands were excised from gel, and radioactivity
was measured in a liquid scintillation counter (Beckman Coulter).
Assay of gelsolin-PIP2 binding
The PI(4,5)P2 beads were purchased from Echelon Biosciences Incorporated.
Gelsolin-PI(4,5)P2 binding was performed per the manufacturer’s instructions.
In brief, HEK 293 cell lysates expressing Flag-gelsolin with or without PYK2,
PYK2-KD, or FAK were incubated with PI(4,5)P2 beads for 4 h at 4 C. Gelso-
lin-bound beads were subjected to immunoblotting with indicated antibodies.
Generation of adenovirus and infection of osteoclasts
The recombinant, replication-deficient adenoviruses expressing PYK2 and
catalytically inactive PYK2 were generated using the AdEasy™ system (He
et al., 1998). Wild-type and catalytically inactive mutant of PYK2 were
constructed into pTRACK-GFP vector. The recombinant adenoviruses were
generated by homologous recombination between the parental virus ge-
nome and the expression shuttle vector. Recombinant viruses were pro-
duced in the HEK 293 cell line.
Mouse osteoclasts were infected with recombinant adenoviruses at dif-
ferent multiplicities of infection. Adenoviruses were usually applied at day
5 of differentiation, then incubated for 24 h followed by a change of me-
dium. At day 7, cells were washed with PBS, then fixed with 4% PFA for
immunostaining or lysed for Western blotting analysis.
Immunocytochemistry
Cells were fixed with 4% PFA for 20 min, blocked with 10% BSA, and in-
cubated with antibodies against PYK2 (goat polyclonal; Santa Cruz Bio-
technology, Inc.) or gelsolin (monoclonal; Transduction Laboratories).
Double labeled immunostaining was done with appropriate fluorochrome-
conjugated secondary antibodies. Fluorescent images of cells were cap-
tured on a Sony CCD camera mounted on a microscope (model E600; Ni-
kon) using Photoshop
® imaging software.
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